BSE filing, NSE: EMBASSY. Summary written from the filing by ALFA Finder's alert engine.
Embassy Office Parks REIT: key numbers
- Share price
- ₹414.45
- Market cap
- ₹39,285 Cr
- Revenue (annual)
- ₹4,582 Cr
- Net profit (annual)
- ₹338.5 Cr
- Promoter holding
- 0.00%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Embassy Office Parks REIT
All →Embassy Office Parks REIT Q2 FY27 Results: Net Profit ₹831 Cr, Up 257.9% YoY
Embassy Office Parks REIT reported revenue from operations of ₹1,303 Cr (+15.8% YoY) and net profit of ₹831 Cr (+257.9% YoY) for Q2 FY27.
- Key figure
- Net profit ₹831 Cr · +257.9% YoY
Embassy Office Parks REIT Debt & Borrowing: ₹400 Cr
Embassy Office Parks REIT approved the issuance of Commercial Papers (CP Tranche XI) for ₹400 Crore. Proceeds will fund debt repayment and working capital requirements.
- Value
- ₹400.0 Cr
- Execution
- 91 days
Embassy Office Parks REIT Credit Rating
Embassy Office Parks REIT received reaffirmed credit ratings of 'CRISIL A1+' and 'CARE A1+' for its commercial paper programme from CRISIL and CARE Ratings.
Embassy Office Parks REIT Credit Rating
Embassy REIT received revalidated CRISIL A1+ and reaffirmed CARE A1+ ratings for its commercial papers. These ratings indicate strong safety for debt obligations.
- Value
- ₹2,000 Cr
Embassy Office Parks REIT Employee Stock Options
Embassy Office Parks REIT disclosed an off-market transfer of 19,322 units to a designated person under the Employee Incentive Plan 2020.
Embassy Office Parks REIT Earnings Call Transcript: Key Takeaways
Embassy REIT shows robust FY27 start with 17% revenue and NOI growth, driven by massive GCC demand and Bangalore's tech ecosystem. Strong leasing activity (1.3M sq ft) offsets potential delays in specific project blocks.
- Call
- Guides 13% growth
Other employee stock options announcements
All →RateGain Travel Technologies Employee Stock Options
RateGain granted 53,021 Stock Appreciation Rights under its SAR Scheme 2022 at ₹800 and ₹862.25 per unit. The grants vest over four years and are exercisable within three years of vesting.
- Execution
- Vesting over 4 years (10% Y1, 20% Y2, 30% Y3, 40% Y4); exercisable within 3 years of vesting
Aye Finance Employee Stock Options
Aye Finance's employee welfare trust transferred 89,501 equity shares to grantees on exercising ESOP options. The share capital remains unchanged, so no new issuance occurs.
Aarti Pharmalabs Employee Stock Options
Aarti Pharmalabs granted 850 stock options to employees under its PSOP 2023 at Rs.5 exercise price. This is an employee incentive grant, not a capital raise.
OnEMI Technology Solutions Employee Stock Options
OnEMI Technology allotted 69,000 equity shares on exercise of employee stock options under the Kissht ESOP 2022 plan. The shares rank pari passu with existing equity.
Bliss GVS Pharma Employee Stock Options
Bliss GVS Pharma seeks shareholder approval via postal ballot for new employee stock option plans 2026. Up to 26,50,000 options are proposed; voting closes November 27, 2026.
Bandhan Bank Employee Stock Options
Bandhan Bank's board granted 32,98,871 stock options under ESOP Series 1 (Tranche 9) at Rs 151.91 per option. The options vest over four years, with each option convertible into one equity share.